News and Announcements

Novo Nordisk cuts FY sales and operating profit outlook, shares tumble

By Michele Maatouk

Date: Tuesday 29 Jul 2025

(Sharecast News) - Novo Nordisk tumbled on Tuesday after the Danish pharmaceutical group cut its sales and operating profit outlook for 2025.
The obesity drug maker now expects full-year sales growth of between 8% and 14% and operating profit growth of 10% to 16%, both at constant exchange rates. It had...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page